Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
- 1 October 1986
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 74 (4), 758-765
- https://doi.org/10.1161/01.cir.74.4.758
Abstract
In a study of 307 white patients who underwent coronary angiography, the relationship of coronary artery disease (CAD) to plasma levels of lipoprotein Lp(a) and other lipid-lipoprotein variables was examined. Lp(a) resembles low-density lipoprotein (LDL) in several ways, but can be distinguished and quantified by electroimmunoassay. CAD was rated as present or absent and was also represented by a quantitative lesion score derived from estimates of stenosis in four major coronary vessels. Coronary lesion scores significantly correlated with Lp(a), total cholesterol, triglycerides, LDL cholesterol, and high-density lipoprotein (HDL) cholesterol levels by univariate statistical analysis. By multivariate analysis levels of Lp(a) were associated significantly and independently with the presence of CAD (p less than .02), and tended to correlate with lesion scores (p = .06). Among subgroups Lp(a) level was associated with CAD in women of all ages and in men 55 years old or younger. An apparent threshold for coronary risk occurred at Lp(a) lipoprotein mass concentrations of 30 to 40 mg/dl, corresponding to Lp(a) cholesterol concentrations of approximately 10 to 13 mg/dl. Plasma Lp(a) in white patients appears to be a major coronary risk factor with an importance approaching that of the level of LDL or HDL cholesterol.Keywords
This publication has 25 references indexed in Scilit:
- Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged malesClinical Genetics, 2008
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Correlation of the extent of coronary occlusion with Apo B levels Application of a new enzyme immunoassay technique for Apo BAtherosclerosis, 1984
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.JCI Insight, 1983
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a): A dose-response study of the effects of cholestyramine in hypercholesterolaemiaAtherosclerosis, 1982
- Severity of coronary atherosclerosis related to lipoprotein concentration.BMJ, 1978
- Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart diseaseClinical Genetics, 1975
- A study of methods of identification and estimation of LP(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosisAtherosclerosis, 1974
- PAPER II: Angina of Effort and an Extra Pre‐beta Lipoprotein FractionActa Medica Scandinavica, 1972